搜索临床试验以:90Y-Ibritumomab Tiuxetan
总计904个结果
-
Novartis Pharmaceuticals完全的卵巢肿瘤 | 输卵管肿瘤 | 腹膜肿瘤荷兰, 加拿大, 美国, 斯洛伐克, 英国
-
Clinical Nutrition Research Center, Illinois Institute...完全的
-
Chinese University of Hong KongFood and Health Bureau, Hong Kong; Hospital Authority终止
-
Mahidol UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Southeast Asia Influenza Clinical...完全的
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.Qingdao Municipal Hospital; Beijing Luhe Hospital; Cangzhou People's Hospital; First Affiliated... 和其他合作者未知
-
Cardiovascular and Interventional Radiological...完全的
-
Masonic Cancer Center, University of Minnesota终止
-
University of Maryland, BaltimoreGilead Sciences完全的
-
Astellas Pharma IncAstellas Pharma Korea, Inc.完全的
-
DurectCTI Clinical Trial and Consulting Services完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人不可切除的肝细胞癌 | III 期肝细胞癌 AJCC v8 | IIIA 期肝细胞癌 AJCC v8 | IV 期肝细胞癌 AJCC v8 | IVA 期肝细胞癌 AJCC v8 | IVB 期肝细胞癌 AJCC v8 | IIIB 期肝细胞癌 AJCC v8美国
-
University of CopenhagenKU Leuven; University of Minnesota; Technical University of Denmark招聘中
-
AbbottPRA Health Sciences; Datamap完全的女性不孕症比利时, 香港, 新加坡, 中国, 印度, 泰国, 俄罗斯联邦, 澳大利亚, 德国, 乌克兰
-
Cedars-Sinai Medical CenterGenzyme, a Sanofi Company撤销
-
Novartis Pharmaceuticals完全的
-
Nathan Kline Institute for Psychiatric ResearchStanley Medical Research Institute完全的
-
Advanced Bionics终止耳鼻喉科疾病 | 耳部疾病 | 听力损失 | 听力障碍 | 部分耳聋美国
-
Asan Medical CenterAstellas Pharma Korea, Inc.完全的
-
University of PittsburghNational Cancer Institute (NCI)完全的
-
DurectCTI Clinical Trial and Consulting Services完全的
-
University Hospitals, LeicesterNational Institute for Health Research, United Kingdom; University of Leicester完全的